Literature DB >> 27922940

Impact of menopausal status on negative mood and depressive symptoms in a longitudinal sample spanning 20 years.

Katherine E Campbell1, Lorraine Dennerstein, Sue Finch, Cassandra E Szoeke.   

Abstract

OBJECTIVE: Studies examining depressive symptoms and negative mood across the postmenopause are lacking, particularly those that examine prevalence in early and late postmenopause. This study examines negative mood and depressive occurrence in the menopausal stages to provide a better understanding of prevalence of mood disturbance during this period.
METHODS: This study was a longitudinal assessment of variables drawn from an epidemiological prospective study of women's healthy aging. Scores were analyzed using general linear mixed models to determine whether there were reductions in negative mood across the stages of the menopausal transition, including the substages of the early and late postmenopause, as defined by Stages of Reproductive Ageing Workshop+10 criteria. Negative mood scores, derived from the Affectometer 2, were obtained at 11 time points between 1992 and 2012 in a group of 438 Melbourne-based, community-dwelling women aged between 45 and 55 years at baseline (n = 234; 53% retention in 2012). Depressive symptoms were assessed using the Centre for Epidemiological Studies Depression Scale administered at three time points for 10 years.
RESULTS: Women's experience of negative mood and depressive symptoms was highest during the menopausal transition and lowest in the late postmenopause. Increasing age was associated with a reduction in depressive symptoms F(1,559) = 14.83, P < 0.001 and negative mood F(1,935) = 14.97, P < 0.001. When controlling for age, there was no difference found between the early and late postmenopause stage mean scores.
CONCLUSIONS: Although there were differences found between negative mood and depressive symptom scores in relation to categories of reproductive aging, age was found to be the driving influence to their association.

Entities:  

Mesh:

Year:  2017        PMID: 27922940     DOI: 10.1097/GME.0000000000000805

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  12 in total

1.  Estrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: A possible mechanism for menopausal depression.

Authors:  Anindit Chhibber; Sarah K Woody; M A Karim Rumi; Michael J Soares; Liqin Zhao
Journal:  Psychoneuroendocrinology       Date:  2017-05-18       Impact factor: 4.905

2.  Astragalin attenuates depression-like behaviors and memory deficits and promotes M2 microglia polarization by regulating IL-4R/JAK1/STAT6 signaling pathway in a murine model of perimenopausal depression.

Authors:  Guangda Yao; Zijun Bai; Jianguo Niu; Rui Zhang; Youyuan Lu; Tiantian Gao; Hanqing Wang
Journal:  Psychopharmacology (Berl)       Date:  2022-04-12       Impact factor: 4.415

3.  Exploring women's perceptions and experiences of menopause among East Coast Malaysian women.

Authors:  Nurul Najmi Mohamad Ishak; Nurjasmine Aida Jamani; Siti Roshaidai Mohd Arifin; Azwanis Abdul Hadi; Karimah Hanim Abd Aziz
Journal:  Malays Fam Physician       Date:  2021-02-01

Review 4.  N-3 Polyunsatured Fatty Acids in Menopausal Transition: A Systematic Review of Depressive and Cognitive Disorders with Accompanying Vasomotor Symptoms.

Authors:  Valentina Ciappolino; Alessandra Mazzocchi; Paolo Enrico; Marie-Louise Syrén; Giuseppe Delvecchio; Carlo Agostoni; Paolo Brambilla
Journal:  Int J Mol Sci       Date:  2018-06-23       Impact factor: 5.923

5.  A Randomized, Controlled Clinical Trial of Combining Therapy with Traditional Chinese Medicine-Based Psychotherapy and Chinese Herbal Medicine for Menopausal Women with Moderate to Serious Mood Disorder.

Authors:  Yuyan Zeng; Xuchun Huang; Changqian Chen; Guangning Nie; Xiaojing Cao; Jiju Wang; Xiaoyun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-06       Impact factor: 2.629

Review 6.  Psychosomatic and vasomotor symptom changes during transition to menopause.

Authors:  Areti Augoulea; Michalis Moros; Aikaterini Lykeridou; George Kaparos; Rallou Lyberi; Konstantinos Panoulis
Journal:  Prz Menopauzalny       Date:  2019-06-28

7.  High-fat diet intake induces depressive-like behavior in ovariectomized rats.

Authors:  Valter T Boldarine; Amanda P Pedroso; Nelson I P Neto; Ana P S Dornellas; Cláudia M O Nascimento; Lila M Oyama; Eliane B Ribeiro
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

8.  Prediction of risk of depressive symptoms in menopausal women based on hot flash and sweating symptoms: a multicentre study.

Authors:  Yanwei Zheng; Yibei Zhou; Jiangshan Hu; Jieping Zhu; Qi Hua; Minfang Tao
Journal:  Clin Interv Aging       Date:  2017-11-23       Impact factor: 4.458

9.  Establishment and evaluation of a novel mouse model of peri/postmenopausal depression.

Authors:  Ling Zhang; Lu-Lu Cao; Dan-Dan Yang; Jian-Hua Ding; Xu-Dong Guo; Teng-Fei Xue; Xiao-Jie Zhao; Xiu-Lan Sun
Journal:  Heliyon       Date:  2019-02-04

10.  MicroRNA-99a is a Potential Target for Regulating Hypothalamic Synaptic Plasticity in the Peri/Postmenopausal Depression Model.

Authors:  Jin Yang; Ling Zhang; Lu-Lu Cao; Jun Qi; Ping Li; Xi-Peng Wang; Xiu-Lan Sun
Journal:  Cells       Date:  2019-09-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.